Asia Pacific prostate cancer market is expected to grow at a CAGR of 7.9% during the forecast period. As per the World Health Organization, Asia Pacific is the second largest region in terms of new cases of prostate cancer globally. In 2018, around 321,000 new cases of prostate cancer were registered in the region. China has the highest incidence in the region followed by Japan however Australia has a very high incidence rate of prostate cancer. The highest rates of prostate cancer are reported in Australia and New Zealand presumably due to prostate-specific antigen (PSA) screening is done widely in these regions. In Asia Pacific, prostate cancer incidence has been reported to vary from country to country.

Request a Free Sample of our Asia Pacific Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/asia-pacific-prostate-cancer-diagnostic-therapeutic-market

There has been a consistent increase in the age-standardized incidence rates of prostate cancer in Asian countries over the last few decades, particularly in Singapore, China, Malaysia, and Japan. This has been reported to be due to changes in diet and other lifestyle factors in these countries. Moreover, the adoption of innovative technologies for the diagnosis of prostate cancer such as biomarkers and the adoption of personalized medicine for treatment is expected to provide a significant opportunity to the market.
A full Report of Asia Pacific Prostate Cancer Diagnostic and Therapeutic Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-prostate-cancer-diagnostic-therapeutic-market

Asia Pacific Prostate Cancer Market Segmentation

By Diagnostic Techniques

• Prostate-Specific Antigen Test (PSA)
• Digital Rectal Examination
• Prostate Biopsy
• Imaging Techniques

By Therapeutics

• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Radiation Therapy
• Targeted Therapy
• Surgery

Regional Analysis

• China
• Japan
• India
• Rest of Asia Pacific

Company Profiles

• Abbott Laboratories
• AbbVie Products, LLC
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Bristol-Myers Squibb Co.
• Endo Pharmaceuticals Inc.
• Ferring Pharmaceuticals Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Pfizer Inc.
• Siemens Healthcare AG

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-prostate-cancer-diagnostic-therapeutic-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404